BioPlus Acquisition Corp. (BIOS)
NASDAQ: BIOS
· Real-Time Price · USD
10.79
-0.01 (-0.09%)
At close: Oct 06, 2023, 9:46 PM
BioPlus Acquisition Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | 275.27K | 1.17M | 290.37K | 255.42K | 307.19K | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | -1.17M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -1.28M | -275K | -318K | -290K | -255.42K | -307K | -155.41 | -877 | -1.14K | -5 |
Interest Income | 2.52M | 2.6M | 1.89M | 949.5K | 280.35K | 45.37K | n/a | n/a | n/a | n/a |
Pretax Income | 1.24M | 2.32M | 1.57M | 659.13K | 24.92K | -262K | -145.93 | -877 | -1.14K | -5 |
Net Income | 1.24M | 2.32M | 1.57M | 659.13K | 24.92K | -262K | -145.93 | -877 | -1.14K | -5 |
Selling & General & Admin | 1.28M | 275.27 | -853K | 290.37K | 255.42K | 307.19K | 155.41 | 877.00 | 1.14K | 5.00 |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 1.28M | 275.27K | -853K | 290.37K | 255.42K | 307.19K | 155.41 | 877.00 | 1.14K | 5.00 |
Interest Expense | n/a | n/a | 1.14M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 1.28M | 275.27K | 318.21K | 290.37K | 255.42K | 307.19K | 155.41 | 877.00 | 1.14K | 5.00 |
Income Tax Expense | -1.28K | n/a | n/a | n/a | n/a | -307 | 9.49 | -0.88 | -1.14 | n/a |
Shares Outstanding (Basic) | 24.48M | 23.56M | 597.79M | 29.31M | 5.75M | 29.31M | 12.5K | 6.88M | 5.76M | 5K |
Shares Outstanding (Diluted) | 24.48M | 23.56M | 26.43M | 29.31M | 29.31M | 29.31M | 12.5K | 6.88M | 5.75M | 5K |
EPS (Basic) | 0.05 | 0.17 | 0.01 | 0.02 | 0.00 | -0.01 | -0.01 | -0.00 | -0.00 | -0.00 |
EPS (Diluted) | 0.05 | 0.17 | 0.06 | 0.02 | 0.00 | -0.01 | -0.01 | -0.00 | -0.00 | -0.00 |
EBITDA | -1.28M | -275K | -318K | -290K | -255.42K | -307K | 9.49 | -877 | -1.14K | n/a |
EBIT | n/a | n/a | -1.06M | -161K | -250.53K | n/a | n/a | n/a | n/a | n/a |
Depreciation & Amortization | 122.08K | 41.58K | 318.21K | 27.08K | 86.06K | 60.46K | 71.39K | 877.00 | 1.14K | 55.21K |